Lower Drug Costs Are Just a Federal License Away. But They Require Biden Administration Leadership
It’s a longstanding government failure to never use federal “march-in” licensing rights to lower drug prices. It’s also a mistake to limit them to only a few cases
It’s a longstanding government failure to never use federal “march-in” licensing rights to lower drug prices. It’s also a mistake to limit them to only a few cases
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
